2015

Wrong blood in tube – potential for serious outcomes: can it be prevented?Paula H. B. Bolton-Maggs, Erica M. Wood and Johanna C. Wiersum-Osselton. Br J Haematol. 2015 Jan;168(1):3-13. doi: 10.1111/bjh.13137. Epub 2014
Development of standard definitions for surveillance of complications related to blood donation.Goldman M, Land K, Robillard P, Wiersum-Osselton J. Vox Sang. 2015 Sep 11. doi: 10.1111/vox.12323. [Epub ahead of print] PMID: 26361365
Presence of medication taken by blood donors in plasma for transfusionA. J. W. van Tilborgh-de Jong, J. C. Wiersum-Osselton, D. J. Touw & M. R. SchipperusVox Sanguinis Volume 108, no. 4, May 2015
Quality indicators for the hospital transfusion chain: a national survey conducted in 100 dutch hospitalsP.Y. Zijlker-Jansen, M.P. Janssen, A.J.W. van Tilborgh-de Jong, M.R. Schipperus, J.C. Wiersum-OsseltonVox Sanguinis Volume 109, no. 3, October 2015
International survey on definitions and current practices in prevention, diagnosis, management and reporting of transfusion-transmitted bacterial infectionsE. Chew, R.J. Benjamin, C.P. McDonald, J.C. Wiersum-Osselton, E.M. Wood on behalf of the International Society of Blood Transfusion Working Parties on Transfusion-Transmitted Infectious Diseases (Bacterial subgroup) and Haemovigilance.ISBT Science Series 2015: 10(1), 31-40.
New perspectives for tissue banking in EuropeA. Bokhorst, Director TRIP Foundation, National Office for Hemo- and Biovigilance, The NetherlandsPostmortale Gewebespende: Quo Vadis, Jahresband 2014/15 – Stiftung Europäische Gewebebanken

Laatste nieuws

Laatste nieuws

Professor Jon J. van Rood 100 jaar: een fundamentele betekenis voor Transfusie- en Transplantatiegeneeskunde

De nieuwe verordening lichaamsmateriaal 2024/1938: Implicaties voor het veld

TRIP Nieuwsbrief 2026/1